Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

Abstract We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology assessment (HTA) agencies. Therefore, we ide...

Full description

Bibliographic Details
Main Authors: Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13027

Internet

https://doi.org/10.1111/cts.13027

Similar Items